These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 4608660
21. [Pharmacokinetic characteristics and biodegradation of aprindin in man]. Dodion L, de Suray JM, Deblecker M, Georges A. Therapie; 1974; 29(2):221-32. PubMed ID: 4849380 [No Abstract] [Full Text] [Related]
22. Investigation on the cardiovascular effects of aprindine. Mertens HM, Neuhaus KL. Acta Cardiol; 1974; Suppl 18():163-9. PubMed ID: 4547611 [No Abstract] [Full Text] [Related]
23. [Treatment of extrasystoles using a new oral anti-arrhythmic agent Aprindine]. Sterz H. Acta Med Austriaca; 1974; 1(4):127-31. PubMed ID: 4142916 [No Abstract] [Full Text] [Related]
24. [1st experiences with the clinical use of a new antiarrhythmic agent: bunaftide]. Lotto A, Lomanto B, Bossi M. Cardiol Prat; 1972; 23(2):123-33. PubMed ID: 5073277 [No Abstract] [Full Text] [Related]
25. [Effects of aprindine (AC 1802) on myocardial function in man]. Besse P, Choussat A. Acta Cardiol; 1974; Suppl 18():217-31. PubMed ID: 4547426 [No Abstract] [Full Text] [Related]
32. [Comparative evaluation of the anti-arrhythmia effectiveness of mezotrin and izoptin]. Dzhishambaev ED, Ivanova LA, Bugriĭ EM, Mazur NA, Pavlova TS. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986 Jan; 9(2):40-4. PubMed ID: 3541963 [Abstract] [Full Text] [Related]
33. Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent. Georges A, Hosslet A, Duvernay G. Acta Cardiol; 1973 Jan; 28(2):166-91. PubMed ID: 4540792 [No Abstract] [Full Text] [Related]
34. Model for exchange kinetics of aprindine in man after single and multiple doses. Delcroix C, Martin L, Van Durme JP, Kesteloot H, Hagemeijer F, Mbuyamba P, Deblecker M. Acta Cardiol; 1974 Jan; Suppl 18():177-94. PubMed ID: 4547521 [No Abstract] [Full Text] [Related]
36. [Some side-effects of bunaftine in direct venous administration]. Veglia L, Basile F, Guerricchio G. Boll Soc Ital Cardiol; 1975 Jan; 20(4):371-6. PubMed ID: 1231918 [No Abstract] [Full Text] [Related]
37. Antiarrhythmic agents. Campbell TJ. Med J Aust; 1984 Nov 24; 141(11):718-23. PubMed ID: 6390099 [No Abstract] [Full Text] [Related]
38. The hemodynamic effects of Norpace. (Part II). Willis PW. Angiology; 1975 Jan 24; 26(1 Pt 2):102-10. PubMed ID: 1115396 [No Abstract] [Full Text] [Related]
39. [Methodological critiques of protocols of clinical studies of anti-arrhythmia agents]. Boissel JP, Leizorovicz A, Peyrieux JC, Alamzecery Y. Arch Mal Coeur Vaiss; 1981 Dec 24; 74 Spec No():91-6. PubMed ID: 6803707 [No Abstract] [Full Text] [Related]
40. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone. Furlanello F, Disertori M, Vergara G, Guarnerio M, Dal Forno P, Padrini R, Gobbato S, Ferrari M. Int J Clin Pharmacol Res; 1983 Dec 24; 3(2):101-5. PubMed ID: 6679511 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]